title: Pardaxin, a new pharmacological tool to stimulate the arachidonic acid cascade in PC12 cells.
abstract: The effect of Pardaxin, a neurotoxin that induces neurotransmitter release from neurons, on the arachidonic acid (AA) cascade was studied in PC12 cells. Both native and the synthetic Pardaxin selectively stimulated phospholipase A2 (PLA2) activity (measured by [3H]AA release) in the presence as well as in the absence of extracellular calcium. Pardaxin-stimulated PLA2 activity was also evident in the increased formation of lysophosphatidylcholine. Pardaxin analogs, lacking the alpha-helical structure that is essential for insertion into the plasma membrane, were ineffective in stimulating the AA cascade in PC12 cells. Pardaxin stimulation of PLA2 was markedly inhibited by the nonselective PLA2 inhibitors bromophenacyl bromide and mepacrine, by methyl arachidonyl fluorophosphonate, a dual inhibitor of calcium-dependent cytosolic PLA2 and the calcium-independent PLA2 and by bromoenol lactone[(E)-6-(bromoethylene)tetrahydro-3-(1-naphthalenyl-2H-pyran -2- one], a highly specific inhibitor of calcium-independent PLA2. After Pardaxin treatment, there was increased release of AA metabolites produced by the cyclooxygenase pathway as expressed in an 8-fold increase of PGE2 release. The release of other eicosanoids, such as 6-keto-PGF1alpha and thromboxane B2, was also augmented. Pardaxin-induced PGE2 release was observed in calcium-free medium and in the absence of any increase in cytosolic calcium. Dexamethasone partially inhibited Pardaxin-induced PGE2 release. This effect was reversed by the type II corticosteroid receptor antagonist RU-38486. Our results indicate that Pardaxin stimulates release of AA and eicosanoids, independently of calcium, and suggest that calcium-independent PLA2 plays an important role in Pardaxin stimulation of the AA cascade.
authors.affiliation: Department of Pharmacology and Experimental Therapeutics, School of Pharmacy, Faculty of Medicine, The Hebrew University, Jerusalem, Israel.
authors.forename: S
authors.initials: S
authors.lastname: Abu-Raya
authors.forename: E
authors.initials: E
authors.lastname: Bloch-Shilderman
authors.forename: E
authors.initials: E
authors.lastname: Shohami
authors.forename: V
authors.initials: V
authors.lastname: Trembovler
authors.forename: Y
authors.initials: Y
authors.lastname: Shai
authors.forename: J
authors.initials: J
authors.lastname: Weidenfeld
authors.forename: S
authors.initials: S
authors.lastname: Yedgar
authors.forename: Y
authors.initials: Y
authors.lastname: Gutman
authors.forename: P
authors.initials: P
authors.lastname: Lazarovici
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism*; D002118:Calcium / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism; D005397:Fish Venoms / Q000138:chemical synthesis / Q000302:isolation & purification / Q000494:pharmacology*; D008969:Molecular Sequence Data; D009498:Neurotoxins / Q000494:pharmacology*; D016716:PC12 Cells; D010741:Phospholipases A / Q000378:metabolism; D054467:Phospholipases A2; D051381:Rats; D015854:Up-Regulation
chemical_list: D005397:Fish Venoms; D009498:Neurotoxins; D016718:Arachidonic Acid; C017603:pardaxin; D010741:Phospholipases A; D054467:Phospholipases A2; D015232:Dinoprostone; D002118:Calcium